rss
Br J Ophthalmol 2007;91:1430-1434 doi:10.1136/bjo.2007.119867
  • World view

Randomised equivalency trial comparing 2.5% povidone-iodine eye drops and ophthalmic chloramphenicol for preventing neonatal conjunctivitis in a trachoma endemic area in southern Mexico

  1. Marco A Ramirez-Ortiz1,
  2. Manuel Rodriguez-Almaraz1,
  3. Héctor Ochoa-DiazLopez2,
  4. Paulina Diaz-Prieto2,
  5. Romeo S Rodriguez-Suárez3
  1. 1
    Department of Ophthalmology, Hospital Infantil de México Federico Gómez, Mexico City, Mexico
  2. 2
    Health Division, Colegio de la Frontera Sur, San Cristóbal de Las Casas, Chiapas, Mexico
  3. 3
    Health Adviser Coordinator, Ministry of Health, Mexico
  1. Dr Marco A Ramirez-Ortiz, Department of Ophthalmology, Hospital Infantil de México Federico Gómez, Calle Doctor Marquez 162, Colonia Doctores, CP 06720, Mexico City, Mexico; marco{at}servidor.unam.mx
  • Accepted 2 May 2007

Abstract

Aim: To evaluate the effectiveness of 2.5% povidone-iodine eye drops (PIED) compared with ophthalmic chloramphenicol (OC) for preventing neonatal conjunctivitis.

Methods: 2004 neonates were enrolled from three rural hospitals in a trachoma endemic area. They were randomly assigned to receive either PIED (n = 1024) or OC (n = 974). Infectious conjunctivitis was confirmed by laboratory methods, including specific search for Chlamydia trachomatis by polymerase chain reaction assay.

Results: During the first 48 hours after birth, PIED and OC had similar efficacy against bacterial conjunctivitis (95% confidence interval (CI), −0.031 to −0.004; p = 0.01); from day 3 to day 15, PIED was 6% less effective than OC (95% CI, −0.058 to −0.006; p = 0.01); after day 16 there was no significant difference between the groups (95% CI, −0.022 to 0.041; p = 0.57). However, the risk of C trachomatis conjunctivitis was increased in neonates receiving PIED prophylaxis (relative risk = 1.99 (95% CI, 1.07 to 3.71), log-rank p = 0.029). Ocular side effects were rare and self limiting in both groups (p = 0.223).

Conclusions: PIED seems to increase the risk of acquiring chlamydial conjunctivitis in neonates. Additional measures are required to prevent mother to fetus transmission of chlamydial infection during pregnancy, delivery, and after birth.

Footnotes

  • Competing interests: None declared.

  • Abbreviations:
    OC

    ophthalmic chloramphenicol

    PIED

    povidone-iodine eye drops

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.